Home / Inspections / 1166895

FDA Inspection 1166895 — TriRx Huntsville Pharmaceutical Services, LLC

TriRx Huntsville Pharmaceutical Services, LLC — FEI 3003197096

The FDA completed an inspection of TriRx Huntsville Pharmaceutical Services, LLC on April 1, 2022 in Huntsville, AL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 1, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Huntsville, AL (United States)

Facility

Other inspections at this facility

  • 1216782 (NAI Fri Aug 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 978625 (NAI Thu Apr 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 908381 (VAI Fri Dec 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 891076 (VAI Fri Aug 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 888276 (NAI Thu Jul 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources